Immunotherapy of AIDS

Current Opinion in Biotechnology
A G Dalgleish


The immunotherapy of AIDS encompasses a broad range of therapeutic possibilities. A number of stimulating and immunomodulating agents have been tried without any overt success. More recently, passive immunotherapy of AIDS using donated plasma and active therapeutic vaccine procedures have been reported. A number of clinical and laboratory observations together with preliminary results of clinical trials suggest that post-infection vaccines may be able to delay progression to disease in some individuals.


Jan 11, 1992·Lancet·G PizzoloG Semenzato
Apr 4, 1992·Lancet·A G DalgleishJ Habeshaw
Mar 1, 1992·Scandinavian Journal of Immunology·M B ZaitsevaB B Brondz
Apr 1, 1991·Immunological Reviews·D KabelitzO Janssen
Aug 1, 1991·The Journal of Experimental Medicine·Q J Sattentau, J P Moore
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D D HoN C Sun
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D R BurtonR A Lerner
Jan 1, 1991·Viral Immunology·S H LiangD Herlyn
Jan 1, 1992·Immunology Today·V Veljković, R Metlas
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S KarpatkinY H Kouri
Jan 1, 1991·Journal of Clinical Laboratory Analysis·J HinkulaB Wahren
Oct 3, 1991·Nature·E J Stott
Jan 1, 1991·Annual Review of Immunology·J McCuneM Lieberman
Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M K HartB F Haynes
Jan 1, 1991·Clinical Immunology and Immunopathology·I SekigawaR A Byrn
Mar 1, 1991·Trends in Pharmacological Sciences·J W Hadden
Jan 1, 1990·International Reviews of Immunology·A Aldovini, R A Young

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Biological Therapy
Nishith SinghJames L Gulley
Current Treatment Options in Oncology
Alicia TerandoVernon K Sondak
Infectious Disease Clinics of North America
Cristian Speil, Robert Rzepka
Progress in Growth Factor Research
A von Rohr, N Thatcher
© 2021 Meta ULC. All rights reserved